These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12532089)

  • 1. Update on glucocorticoid action and resistance.
    Leung DY; Bloom JW
    J Allergy Clin Immunol; 2003 Jan; 111(1):3-22; quiz 23. PubMed ID: 12532089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.
    Song QQ; Xie WY; Tang YJ; Zhang J; Liu J
    Pharmacogenomics; 2017 Feb; 18(3):293-316. PubMed ID: 28112586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of glucocorticoid sensitivity and its potential clinical applicability.
    Longui CA; Faria CD
    Horm Res; 2009; 71(6):305-9. PubMed ID: 19506386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on glucocorticoid action and resistance.
    Ito K; Chung KF; Adcock IM
    J Allergy Clin Immunol; 2006 Mar; 117(3):522-43. PubMed ID: 16522450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The mechanism of glucocorticoid resistance in multiple sclerosis].
    Rzazewska-Makosa B
    Postepy Hig Med Dosw (Online); 2005 Sep; 59():457-63. PubMed ID: 16177666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids and inflammation revisited: the state of the art. NIH clinical staff conference.
    Franchimont D; Kino T; Galon J; Meduri GU; Chrousos G
    Neuroimmunomodulation; 2002-2003; 10(5):247-60. PubMed ID: 12759562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease.
    Lucafò M; Di Silvestre A; Romano M; Avian A; Antonelli R; Martelossi S; Naviglio S; Tommasini A; Stocco G; Ventura A; Decorti G; De Iudicibus S
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):87-93. PubMed ID: 28722800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Glance at the Use of Glucocorticoids in Rare Inflammatory and Autoimmune Diseases: Still an Indispensable Pharmacological Tool?
    Ronchetti S; Ayroldi E; Ricci E; Gentili M; Migliorati G; Riccardi C
    Front Immunol; 2020; 11():613435. PubMed ID: 33584696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update.
    Nicolaides NC; Charmandari E
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in glucocorticoid resistance.
    Yang N; Ray DW; Matthews LC
    Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-unresponsive asthma.
    Leung DY; Spahn JD; Szefler SJ
    Semin Respir Crit Care Med; 2002 Aug; 23(4):387-98. PubMed ID: 16088632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps.
    Choi BR; Kwon JH; Gong SJ; Kwon MS; Cho JH; Kim JH; Oh S; Roh HJ; Kim DE
    Exp Mol Med; 2006 Oct; 38(5):466-73. PubMed ID: 17079862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is certain in glucocorticoid therapy of internal diseases?].
    Gerdes H
    Internist (Berl); 1971 Dec; 12(12):512-7. PubMed ID: 4944682
    [No Abstract]   [Full Text] [Related]  

  • 14. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid resistance as a major drive in sepsis pathology.
    Dendoncker K; Libert C
    Cytokine Growth Factor Rev; 2017 Jun; 35():85-96. PubMed ID: 28479044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and COVID-19.
    Bruscoli S; Puzzovio PG; Zaimi M; Tiligada K; Levi-Schaffer F; Riccardi C
    Pharmacol Res; 2022 Nov; 185():106511. PubMed ID: 36243331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases.
    Andreae J; Tripmacher R; Weltrich R; Rohde W; Keitzer R; Wahn U; Paul K; Buttgereit F
    Pediatr Res; 2001 Jan; 49(1):130-5. PubMed ID: 11134503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.
    Dubois-Camacho K; Ottum PA; Franco-Muñoz D; De la Fuente M; Torres-Riquelme A; Díaz-Jiménez D; Olivares-Morales M; Astudillo G; Quera R; Hermoso MA
    World J Gastroenterol; 2017 Sep; 23(36):6628-6638. PubMed ID: 29085208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids and chronic inflammation.
    Straub RH; Cutolo M
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii6-ii14. PubMed ID: 27856655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of glucocorticoid-resistant asthma.
    Leung DY; de Castro M; Szefler SJ; Chrousos GP
    Ann N Y Acad Sci; 1998 May; 840():735-46. PubMed ID: 9629300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.